“Closing Date Acquisition Agreement” means the Business Combination Agreement, dated as of December 22, 2021 (as amended, restated, supplemented or otherwise modified from time to time), by and among the Borrower, Quidel, Laguna Merger Sub, Inc., a Delaware corporation, Orca Holdco, Inc., a Delaware corporation, Orca Holdco 2, Inc., a Delaware corporation, and Ortho.
“Closing Date Refinancing” means (x) the repayment in full of all outstanding indebtedness under that certain Credit Agreement, dated as of June 30, 2014 (as amended by that certain First Amendment to Credit Agreement, dated as of June 6, 2017, as further amended by that Second Amendment to Credit Agreement, dated as of June 8, 2018, as further amended by that Third Amendment to Credit Agreement, dated as of January 7, 2020, as further amended by that Fourth Amendment to Credit Agreement, dated as of January 27, 2020, as further amended by that certain Fifth Amendment to Credit Agreement, dated as of February 5, 2021, as further amended by that certain Sixth Amendment to Credit Agreement, dated as of December 24, 2021 and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among Ortho-Clinical Diagnostics S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, Ortho-Clinical Diagnostics, Inc., a New York corporation, Ortho-Clinical Diagnostics Holdings Luxembourg S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, the lenders from time to time party thereto and Barclays Bank PLC, as administrative agent and as collateral agent (the “Existing Ortho Credit Agreement”), (y) the satisfaction and discharge of (1) that certain Indenture, dated as of January 27, 2020, by and among Ortho-Clinical Diagnostics S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, Ortho-Clinical Diagnostics, Inc., a New York corporation, the guarantors from time to time party thereto and Wilmington Trust, National Association, as trustee, relating to Ortho’s 7.250% Senior Notes due 2028 and (2) that certain Indenture, dated as of June 11, 2020, by and among Ortho-Clinical Diagnostics S.A., a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, Ortho-Clinical Diagnostics, Inc., a New York corporation, the guarantors from time to time party thereto and Wilmington Trust, National Association, as trustee, relating to Ortho’s 7.375% Senior Notes due 2025, and (z) the termination of that certain Amended and Restated Credit Agreement, dated as of August 31, 2018 (as amended, restated, supplemented or otherwise modified prior to the date hereof), by and among Quidel, each lender from time to time party thereto and Bank of America, N.A., as Administrative Agent, L/C Issuer and Swing Line Lender (the “Existing Quidel Credit Agreement” and together with the Existing Ortho Credit Agreement, the “Existing Credit Agreements”).
“CME” means CME Group Benchmark Administration Limited.
“Code” means the Internal Revenue Code of 1986, as amended.
“Collateral” means all of the “Collateral” or other similar term referred to in the Collateral Documents and all of the other property that is or is intended under the terms of the Collateral Documents to be subject to Liens in favor of the Administrative Agent for the benefit of the Secured Parties.
“Collateral Documents” means, collectively, the Security Agreement, the Intellectual Property Security Agreements, each of the collateral assignments, Security Agreement Supplements, security agreements, pledge agreements or other similar agreements delivered to the Administrative Agent pursuant to Section 6.12, and each of the other agreements, instruments or documents that creates or purports to create a Lien in favor of the Administrative Agent for the benefit of the Secured Parties.
“Commitment” means a Term Commitment or a Revolving Credit Commitment, as the context may require.
“Commitment Fee” has the meaning specified in Section 2.09(a).
7